Lv31
230 积分 2023-11-24 加入
Discovery and Preclinical Pharmacology of NX-2127, an Orally Bioavailable Degrader of Bruton’s Tyrosine Kinase with Immunomodulatory Activity for the Treatment of Patients with B Cell Malignancies
14天前
已完结
Combination of Targeted Drugs to Control Chronic Lymphocytic Leukemia
20天前
已完结
Venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (CLL14): follow-up results from a multicentre, open-label, randomised, phase 3 trial
29天前
已完结
Combination of Targeted Drugs to Control Chronic Lymphocytic Leukemia
29天前
已完结
Prognostic value and therapeutic targeting of XPO1 in chronic lymphocytic leukemia
1个月前
已完结
Altered Expression of Functional Proteins in CD4 Regulatory T Cells during Therapy with Idelalisib
1个月前
已关闭
PI3Kδ inhibition modulates regulatory and effector T-cell differentiation and function in chronic lymphocytic leukemia
1个月前
已完结
The TEMPI Syndrome — A Novel Multisystem Disease
1个月前
已完结
Antigen presentation by macrophages is enhanced by the uptake of necrotic, but not apoptotic, cells
1个月前
已完结
Toll-like receptor 4 signaling: A common pathway for interactions between prooxidants and extracellular disulfide high mobility group box 1 (HMGB1) protein-coupled activation
1个月前
已关闭
皖公网安备34019202002308
